sitaxentan sodium medication treatment pulmonary arterial hypertension marketed thelin encysive pharmaceuticals pfizer purchased encysive february pfizer voluntarily removed sitaxentan market due concerns liver sitaxentan small molecule blocks action endothelin et endothelina eta receptor selectively factor compared sulfonamide class endothelin receptor antagonist era undergoing food drug administration fda review treating pulmonary hypertension rationale benefit compared bosentan nonselective et blocker negligible inhibition beneficial effects etb stimulation nitric oxide production clearance et circulation clinical trials efficacy sitaxentan much bosentan hepatotoxicity sitaxentan outweighs benefits dosing daily opposed twice daily bosentan december pfizer announced would withdrawing sitaxentan worldwide marketing clinical study use citing cause fatal liver sitaxentan approved marketing european union canada australia february launched commercially germany austria netherlands united kingdom ireland france spain italy march fda recommended approvable status sitaxentan said would yet approve product july sitaxentan received second approvable letter stating efficacy outcome issues raised context study still unresolved july encysive commenced formal dispute resolution process preliminary meeting fda september company announced making preparations another phase iii clinical trial intended named overcome fdas takeover pfizer resulted reconfiguration extension plans include combination therapy sildenafil sitaxentan efficacy safety trial randomized prospective assessment adding sildenafil srpaas ongoing program three clinical trials conducted united states clinicalttrialsgov identifiers anticipated completion dates june january adverse effects observed sitaxentan class effects endothelin receptor antagonists include sitaxentan inhibits metabolism warfarin decreased dose warfarin needed coadministered sitaxentan warfarin acts prevent blood clotting remains unmetabolized continue thin blood httpsenwikipediaorgwikisitaxentan